Recreational drug-induced psychosis: a literature review
DOI:
https://doi.org/10.33448/rsd-v10i2.12459Keywords:
Psychosis; Psychotic disorders; Substances; Recreational drugs.Abstract
Psychosis is a broad term that characterizes a series of disorders that have in common the production of so-called psychotic symptoms, mainly delusions and hallucinations. Psychotic disorders can be divided into primary and secondary, including substance-induced psychotic disorders in this last category, among which recreational drugs stand out. The aim of this review was to analyze the main pathophysiological, symptomatic, diagnostic and therapeutic characteristics of psychotic disorders related to the use of recreational drugs. A search for previous works was carried out on the SciELO, Lilacs and PubMed platforms and a total of 27 scientific articles were included after application of inclusion and exclusion criteria. Through the studies analyzed, it was observed that the drugs most often associated with psychotic disorders were cannabis, amphetamines, alcohol and cocaine, with delusions, especially persecutory, and auditory hallucinations being the main reported symptoms. Although the pathophysiology of these disorders is not completely understood, there is evidence that the use of illicit drugs is a risk factor for the development of psychotic events, therefore, the knowledge of the factors involved in this relationship is important in clinical practice. In conclusion, it is important that health professionals know that the use of recreational drugs can lead to the development of psychosis and that they know how to assess the best way to approach these patients so that they can offer the best possible support.
References
Albobali, Y., & Madi, M. Y. (2019). Polysubstance Use Disorder After Sleeve Gastrectomy. Cureus, 11(4), e4388.
American Psychiatric Association. (2013). Transtornos relacionados a substâncias. Em Manual diagnóstico e estatístico de transtornos mentais (5a ed.). Whashington DC., Estados Unidos da América.
Barrio, P., Gaskell, M., Goti, J., Vilardell, S., & Fàbregas, J. (2016). Síntomas psicóticos persistentes después del uso abusivo prolongado de mefedrona: una serie de dos casos. Adicciones, 28(3), 154-157.
Björkenstam, E., Björkenstam, C., Hjern, A., Reutfors, J., & Bodén, R. (2013). A five year diagnostic follow-up of 1,840 patients after a first episode non-schizophrenia and non-affective psychosis. Schizophrenia research, 150(1), 205–210.
Bramness, J. G., & Rognli, E. B. (2016). Psychosis induced by amphetamines. Current opinion in psychiatry, 29(4), 236–241.
Carlini, E. A., Galduróz, J. C., Silva, A. M., Noto, A. R., Fonseca, A. M., Carlini, C. M., Oliveira, L. G. et al. (2006). Principais resultados gerais do Brasil – 2005. Em II Levantamento domiciliar sobre o uso de drogas psicotrópicas no Brasil: estudo envolvendo as 108 maiores cidades do país. São Paulo, Brasil.
Chan, W. L., Wood, D. M., Hudson, S., & Dargan, P. I. (2013). Acute psychosis associated with recreational use of benzofuran 6-(2-aminopropyl) benzofuran (6-APB) and cannabis. Journal of medical toxicology: official journal of the American College of Medical Toxicology, 9(3), 278–281.
Chin, J., Forzani, B., Chowdhury, N., Lombardo, S., Rizzo, J. R., & Ragucci, M. (2015). Rehabilitation essential in the recovery of multifactorial subacute combined degeneration. Annals of physical and rehabilitation medicine, 58(3), 190–192.
Colizzi, M., Ruggeri, M., & Bhattacharyya, S. (2020). Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition. Frontiers in psychology, 11, 833.
Dannatt, L., Cloete, K. J., Kidd, M., & Weich, L. (2014). Frequency and correlates of comorbid psychiatric illness in patients with heroin use disorder admitted to Stikland Opioid Detoxification Unit. South Africa. South African Journal of Psychiatry, 20(3), 77-82.
Dos Santos, R. G., Bouso, J. C., & Hallak, J. (2017). Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies. Therapeutic advances in psychopharmacology, 7(4), 141–157.
Fantegrossi, W. E., Wilson, C. D., & Berquist, M. D. (2018). Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems. Drug metabolism reviews, 50(1), 65–73.
Fielitz, P., Suárez, H., Escobal, M., Frontini, M. A., López-Rega, G., Navarro, V., Rodríguez-Formoso, L., Storch, A., García, S., & Campo, O. (2010). Consumo de sustancias psicoactivas en pacientes con trastornos psicóticos ingresados en Sala de Emergencia psiquiátrica: Hospital Vilardebó. Montevideo. Uruguay. Revista chilena de neuro-psiquiatría, 48(2), 106-113.
Filho, F. P., & Silveira, L. C. (2014). Psicose e drogadição: a construção do caso na clínica de enfermagem. SMAD. Revista eletrônica saúde mental álcool e drogas, 10(1), 29-34.
Fiorentini, A., Volonteri, L. S., Dragogna, F., Rovera, C., Maffini, M., Mauri, M. C., & Altamura, C. A. (2011). Substance-induced psychoses: a critical review of the literature. Current drug abuse reviews, 4(4), 228–240.
Fontanella, B. J. B. (2010). Sintomas psicóticos e cognitivos associados à busca de tratamento por dependentes de substâncias: um estudo qualitativo. Jornal Brasileiro de Psiquiatria, 59(2), 139-145.
Fullajtar, M., & Ferencz, C. (2012). Dizájner drog indukálta pszichózis. Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet lapja, 14(2), 137–140.
Fundação Oswaldo Cruz, & Instituto de Comunicação e Informação Científica e Tecnológica em Saúde. (2017). Características gerais da população de pesquisa. Em III Levantamento Nacional sobre o uso de drogas pela população brasileira. Rio de Janeiro, Brasil.
Gerlach, J., Koret, B., Gereš, N., Matić, K., Prskalo-Čule, D., Zadravec Vrbanc, T., Lovretić, V., Skopljak, K., Matoš, T., Šimunović Filipčić, I., & Filipčić, I. (2019). Clinical Challenges in Patients with First Episode Psychosis and Cannabis Use: Mini-Review and a Case Study. Psychiatria Danubina, 31(suppl 2), 162–170.
Glasner-Edwards, S., & Mooney, L. J. (2014). Methamphetamine psychosis: epidemiology and management. CNS drugs, 28(12), 1115–1126.
Grover, S., & Ghosh, A. (2018). Delirium Tremens: Assessment and Management. Journal of clinical and experimental hepatology, 8(4), 460–470.
Guimarães, P. M., Passos, S. R., Calvet, G. A., Hökerberg, Y. H., Lessa, J. L., & Andrade, C. A. (2014). Suicide risk and alcohol and drug abuse in outpatients with HIV infection and Chagas disease. Brazilian Journal of Psychiatry, 36(2), 131-137.
Ham, S., Kim, T. K., Chung, S., & Im, H. I. (2017). Drug Abuse and Psychosis: New Insights into Drug-induced Psychosis. Experimental neurobiology, 26(1), 11–24.
Hindley, G., Beck, K., Borgan, F., Ginestet, C. E., McCutcheon, R., Kleinloog, D., Ganesh, S., Radhakrishnan, R., D'Souza, D. C., & Howes, O. D. (2020). Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. The lancet. Psychiatry, 7(4), 344–353.
Ikawa, H., Kanata, S., Akahane, A., Tochigi, M., Hayashi, N., & Ikebuchi, E. (2019). A case of methamphetamine use disorder presenting a condition of ultra-rapid cycler bipolar disorder. SAGE open medical case reports, 7, 2050313X19827739.
Jordaan, G. P., & Emsley, R. (2014). Alcohol-induced psychotic disorder: a review. Metabolic brain disease, 29(2), 231–243.
Karila, L., Petit, A., Phan, O., & Reynaud, M. (2010). Les troubles psychotiques induits par la cocaïne: une revue synthétique. Revue medicale de Liege, 65(11), 623–627.
Kilciksiz, C. M., Keefe, R., Benoit, J., Öngür, D., & Torous, J. (2020). Verbal memory measurement towards digital perspectives in first-episode psychosis: A review. Schizophrenia Research: Cognition, 21, 100177.
Kurtom, M., Henning, A., & Espiridion, E. D. (2019). Hallucinogen-persisting Perception Disorder in a 21-year-old Man. Cureus, 11(2), e4077.
Mancheno, J. M., Orellana, M. R., Muñoz J. F., Rodas, L. M., Reyes, K. A., Almeida, A. G., & Vázquez P. A. (2019). Prevalencia de patología dual en el centro de reposo y adicciones (CRA). Cuenca, abril ¬ diciembre 2016. Revista de la faculdad de ciencias médicas de la universidad de cuenca, 37(2), 31–39.
Mancke, F., Kaklauskaitė, G., Kollmer, J., & Weiler, M. (2016). Psychiatric comorbidities in a young man with subacute myelopathy induced by abusive nitrous oxide consumption: a case report. Substance abuse and rehabilitation, 7, 155–159.
Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M., & Vassos, E. (2016). Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis. Schizophrenia bulletin, 42(5), 1262–1269.
Müller, F., Dolder, P. C., Schmidt, A., Liechti, M. E., & Borgwardt, S. (2018). Altered network hub connectivity after acute LSD administration. NeuroImage. Clinical, 18, 694–701.
Murrie, B., Lappin, J., Large, M., & Sara, G. (2020). Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis. Schizophrenia bulletin, 46(3), 505–516.
Neyra-Ontaneda, Diego. (2017). Psicosis inducida por ayahuasca: reporte de un caso. Revista de Neuro-Psiquiatría, 80(4), 265-272.
Palma-Álvarez, R. F., Ros-Cucurull, E., Ramos-Quiroga, J. A., Roncero, C., & Grau-López, L. (2019). Cocaine-Induced Psychosis and Asenapine as Treatment: A Case Study. Psychopharmacology bulletin, 49(1), 92–97.
Pearson, N. T., & Berry, J. H. (2019). Cannabis and Psychosis Through the Lens of DSM-5. International journal of environmental research and public health, 16(21), 4149.
Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica [recurso eletrônico] – 1. ed. – Santa Maria, RS: UFSM, NTE.
Personne, M., Westerbergh, J., & Hammer-Pettersen, L. (2014). »Spice« - syntetiska kannabinoider med riskabla effekter - Fall av akut njursvikt och cerebral ischemi med stroke har rapporterats. Lakartidningen, 111(47), 2105–2107.
Redes, L., Brescia, M.S., Wschebor, M., & Gutiérrez, M. (2013). Acerca de un caso clínico de patologia dual de psicosis y consumo de sustancias. Revista Psiquiatría del Uruguay, 77(1), 68-74.
Revilla-Zúñiga, J., Rivera-Encinas, M. T., & Cruzado, L. (2016). Diagnóstico erróneo de psicosis inducida por cocaína en una persona con esquizofrenia y masticadora de hojas de coca. Revista de Neuro-Psiquiatría, 79(2), 119-126.
Roncero, C., Ros-Cucurull, E., Daigre, C., & Casas, M. (2012). Prevalence and risk factors of psychotic symptoms in cocaine-dependent patients. Actas espanolas de psiquiatria, 40(4), 187–197.
Rounsaville B. J. (2007). DSM-V research agenda: substance abuse/psychosis comorbidity. Schizophrenia bulletin, 33(4), 947–952.
Ryan, J. E., Smeltzer, S. C., & Sharts-Hopko, N. C. (2019). Challenges to studying illicit drug users. Journal of nursing scholarship, 51(4), 480–488.
Sawa, A., & Snyder, S. H. (2003). Schizophrenia: neural mechanisms for novel therapies. Molecular medicine (Cambridge, Mass.), 9(1-2), 3–9.
Silva, C.C, Savian, C.M, Prevedello, B.P, Zamberlan, C., Dalpian, D.M, Santos, B.Z (2018). Acesso e utilização de serviços odontológicos por gestantes: Revisão integrativa de literatura. Ciência & Saúde Coletiva, 25(3), 827-835.
Stankewicz, H. A., Richards, J. R., & Salen, P. (2020). Alcohol Relates Psychosis. In: StatPearls publishing.
Tampi, R. R., Young, J., Hoq, R., Resnick, K., & Tampi, D. J. (2019). Psychotic disorders in late life: a narrative review. Therapeutic advances in psychopharmacology, 9, 2045125319882798.
Tang, Y., Martin, N. L., & Cotes, R. O. (2014). Cocaine-induced psychotic disorders: presentation, mechanism, and management. Journal of dual diagnosis, 10(2), 98–105.
Thirthalli, J., & Benegal, V. (2006). Psychosis among substance users. Current opinion in psychiatry, 19(3), 239–245.
Thomas, E., Lategan, H., Verster, C., Kidd, M., & Weich, L. (2016). Methamphetamine-induced psychosis: Clinical features, treatment modalities and outcomes. The South African journal of psychiatry : SAJP: the journal of the Society of Psychiatrists of South Africa, 22(1), 980.
Tucker, M. G., Kekulawala, S., Kent, M., Mostafa, S., & Harvey, R. (2016). Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report. Journal of medical case reports, 10(1), 242.
Ul Haq, E., Shafiq, A., Khan, A. A., Awan, A. A., Ezad, S., Minteer, W. J., & Omar, B. (2017). "Spice" (Synthetic Marijuana) Induced Acute Myocardial Infarction: A Case Series. Case reports in cardiology, 2017, 9252463.
United Nations Office of Drug and Crime. (2019). Global overview of drug demand and supply. Em World drug report 2019. Viena, Áustria.
Winton-Brown, T. T., Allen, P., Bhattacharyya, S., Borgwardt, S. J., Fusar-Poli, P., Crippa, J. A., Seal, M. L., Martin-Santos, R., Ffytche, D., Zuardi, A. W., Atakan, Z., & McGuire, P. K. (2011).
Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 36(7), 1340–1348.
Zamora-Rodríguez, F. J., Sánchez-Walsen-Hernández, M. R., Guisado-Macias, J. A., & Vaz-Leal, F. J. (2018). Uso de sustancias y curso del trastorno bipolar en una muestra de pacientes hospitalizados. Actas españolas de psiquiatría, 46(5), 183-192.
Zhao, B., Zhao, L., Li, Z., & Zhao, R. (2020). Subacute combined degeneration induced by nitrous oxide inhalation: Two case reports. Medicine, 99(18), e19926.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Daniel Nobrega Medeiros; Juliana Fernandes de Souza Ribeiro; Larissa Alexsandra da Silva Neto Trajano
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
